Amedisys (AMED) Tops Q1 EPS by 11c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q1 EPS of $1.00, $0.11 better than the analyst estimate of $0.89. Revenue for the quarter came in at $556.4 million versus the consensus estimate of $558.81 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
- Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
